Loading...
Dernières publications
-
-
-
Hélène Bricout, Marie‐cécile Levant, Nada Assi, Pascal Crepey, Alexandre Descamps, et al.. The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-22 influenza season. Clinical Microbiology and Infection, 2024, 30 (12), pp.1592-1598. ⟨10.1016/j.cmi.2024.08.012⟩. ⟨hal-04698967⟩
-
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1), pp.1049. ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
95
Notices
63
Mots clés
Biomarkers
Older adults
Influenza-like illness
Antiviral
Vaccine safety and efficacy
Cohort
Confidence
COCONEL cohort surveys
Trust
Calcium phosphorus evaluation
Adults
Healthcare workers
Immunogenicity
Booster response
Europe
Cost of illness
Clinical trials
Post-acute COVID-19 symptoms
Boys
Clinical skills
Cohort study
Adverse effects
Determinants
Vaccines
Hesitancy
Acute kidney injury
Vaccine
Antiviral agents
Virology
Efficacy
Adenoviral vector
Awareness
Influenza vaccines
Alpha variant
France
Breakthrough infections
COVID-19 vaccines
Innate immunity
Sleep
Co-morbidities
Misinformation
Attitude toward vaccines
Adjuvant
Antiviral therapy
Adult
HPV vaccine
Bayes' theorem
COVID-19
Moderate to severe COVID-19
Attitude to health
Community-acquired AKI
C-type lectin receptor
Cystic fibrosis
Chemotherapy
Clinical research
Catch-up
Cancer
Coronavirus
Attitudes
Immunization
Specific populations
Emerging infectious diseases
Attitudes of health personnel
Conjugate pneumococcal vaccine
CERVICOVAGINAL SECRETIONS
Effectiveness
Conditional marketing authorization
Vaccine hesitancy
Coadministration
Care management
Epidemiology
AIDS
Hospitalisations
ANTIRETROVIRAL THERAPY
Attitude
Practices
Elderly
Vaccine effectiveness
Respiratory syncytial virus
Influenza
Clinical practice
Vaccine acceptance
Antiretroviral therapy
AstraZeneca vaccine
Chronic kidney disease
Dialysis
B-lymphocytes
Cohort studies
Assay
Incidence
Administrative claims
HIV
Internet
1790GAHB F
Risk factors
SARS-CoV-2
AON
Immunocompromised
COVID-19 mRNA vaccine
Vaccination